FT Due Diligence

The healthtech sector’s spectacular surge in Spacs and de-Spacs

The Covid-19 pandemic triggered a significant rise in Spac investments in the healthtech sector. While Spacs offer opportunities for healthtech companies, the road to a de-Spac process can be complex and perilous.

More from the FT Due Diligence channel

Discover more content on the topics that inspire, engage and inform the world we live in today at the FT Channels hub.

Discover more​

Follow us

FT Due Diligence

FT Channels, a partnership destination that combines impactful and enriching multimedia content to spark curiosity and encourage discovery. Each vertical brings expert insights from the Financial Times and our Partners into the most pressing issues of our time.


FT Due Diligence is a video channel analysing the fast-moving world of M&A, illuminating the trends behind the complex global transactions and how to unlock value from acquisition deals. The channel alternates between independent reporting from FT journalists and insight on global dealmaking from law firm Baker McKenzie.